Stanniocalcin-1 (STC-1), a downstream effector molecule in latanoprost signaling, acts independent of the FP receptor for intraocular pressure reduction

Prostaglandin F2 alpha (PGF2α) analogues such as latanoprost are common first-line intraocular pressure (IOP) lowering medications. However, their clinical use is limited in some patient populations due to minimal or no IOP lowering response or side effects. In searching for a more targeted approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Roddy, Gavin W., Rinkoski, Tommy A., Monson, Kjersten J., Chowdhury, Uttio Roy, Fautsch, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197809/
https://www.ncbi.nlm.nih.gov/pubmed/32365129
http://dx.doi.org/10.1371/journal.pone.0232591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197809/
https://www.ncbi.nlm.nih.gov/pubmed/32365129
http://dx.doi.org/10.1371/journal.pone.0232591

Ejemplares similares